These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31811008)

  • 1. Sexually transmitted infections among high-risk populations that use treatment as prevention or pre-exposure prophylaxis: a protocol for a systematic review.
    Coudray M; Kiplagat S; Saumell F; Madhivanan P
    BMJ Open; 2019 Dec; 9(12):e032054. PubMed ID: 31811008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of digital interventions based on mobile phones for the prevention of sexually transmitted infections: A systematic review protocol.
    Duarte G; Vanegas J; Bravo G; Rada G; Pantoja T
    Medwave; 2019 Mar; 19(2):e7605. PubMed ID: 31075091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Sangani P; Rutherford G; Wilkinson D
    Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Wilkinson D; Rutherford G
    Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model.
    Kasaie P; Berry SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; Pennington J; German D; Flynn CP; Beyrer C; Dowdy DW
    Sex Transm Dis; 2018 Dec; 45(12):791-797. PubMed ID: 29944642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done?
    Kenyon C; Van Dijck C; Florence E
    Curr Opin Infect Dis; 2020 Feb; 33(1):51-58. PubMed ID: 31789694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "The Main Concern is HIV, Everything Else is Fixable": Indifference Toward Sexually Transmitted Infections in the Era of Biomedical HIV Prevention.
    Sarno EL; Macapagal K; Newcomb ME
    AIDS Behav; 2021 Aug; 25(8):2657-2660. PubMed ID: 33745099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.
    Freeborn K; Portillo CJ
    J Clin Nurs; 2018 Sep; 27(17-18):3254-3265. PubMed ID: 28771856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study.
    Bil JP; van der Veldt WM; Prins M; Stolte IG; Davidovich U
    Medicine (Baltimore); 2016 Sep; 95(39):e4910. PubMed ID: 27684827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV pre-exposure prophylaxis and the 'problems' of reduced condom use and sexually transmitted infections in Australia: a critical analysis from an evidence-making intervention perspective.
    Holt M; Newman CE; Lancaster K; Smith AK; Hughes S; Truong HM
    Sociol Health Illn; 2019 Nov; 41(8):1535-1548. PubMed ID: 31215066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences Between Groups of Pre-exposure Prophylaxis (PrEP) Using Couples in HIV-Negative/Unknown Relationships.
    John SA; Robles G; Starks TJ; Rendina HJ
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):419-428. PubMed ID: 30985555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taiwan guideline on oral pre-exposure prophylaxis for HIV prevention - 2018 update.
    Yen-Hao Chu I; Wen-Wei Ku S; Li CW; Toh HS; Yang CJ; Wu KS; Wu HJ; Chen SS; Kuo JH; Lin HH; Ko NY
    J Microbiol Immunol Infect; 2020 Feb; 53(1):1-10. PubMed ID: 31628087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of female condom in preventing HIV and sexually transmitted infections: a systematic review protocol.
    Mome RK; Wiyeh AB; Kongnyuy EJ; Wiysonge CS
    BMJ Open; 2018 Aug; 8(8):e023055. PubMed ID: 30082362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equity considerations in outcome measures of the HIV pre-exposure prophylaxis care continuum in high-income countries: a systematic review protocol.
    Cabecinha M; Solomon D; Rait G; Saunders J; Mohammed H; McDonagh LK
    BMJ Open; 2021 Feb; 11(2):e040701. PubMed ID: 33542038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.